Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

CVS Health (1CVS) Stock Forecast & Price Target

See the Price Targets and Ratings of:

1CVS Analyst Ratings

Strong Buy
16Ratings
16Buy0Hold0Sell
Based on 16 analysts giving stock ratings to CVS Health in the past 3 months

1CVS Stock 12 Month Forecast

EUR 102.93▲(30.29% Upside)
Based on 16 Wall Street analysts offering 12 month price targets for CVS Health in the last 3 months. The average price target is EUR 102.93 with a high forecast of EUR 112.37 and a low forecast of EUR 96.18. The average price target represents a 30.29% change from the last price of EUR 79.00.
Highest Price TargetEUR 112.37Average Price TargetEUR 102.93Lowest Price TargetEUR 96.18

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for IT:1CVS
Price TargetFollowArticle
Bank of America SecuritiesEUR 98.88buy25.17%UpsideReiterated10/13/26
Leerink PartnersEUR 106.97→EUR 100.68buy27.44%UpsideReiterated10/12/26
TD CowenEUR 98.88buy25.17%UpsideReiterated10/09/26
RBC CapitalEUR 101.58buy28.58%UpsideReiterated10/07/26
BernsteinEUR 95.29→EUR 100.68buy27.44%UpsideReiterated10/05/26
Evercore ISIEUR 112.37buy42.23%UpsideReiterated10/02/26
Wells FargoEUR 110.57buy39.96%UpsideReiterated09/15/26
UBSEUR 113.26→EUR 106.07buy34.27%UpsideAssigned09/03/26
JefferiesEUR 107.87buy36.54%UpsideReiterated08/31/26
Piper SandlerEUR 101.58buy28.58%UpsideReiterated08/26/26
Argus ResearchEUR 93.49→EUR 102.48buy29.72%UpsideReiterated08/18/26
J.P. MorganEUR 99.78→EUR 106.07buy34.27%UpsideReiterated08/12/26
Morgan StanleyEUR 99.78buy26.30%UpsideAssigned08/10/26
BarclaysEUR 95.29→EUR 97.08buy22.89%UpsideReiterated08/06/26
Truist FinancialEUR 106.07buy34.27%UpsideReiterated08/06/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
OVIDOvid Therapeutics
REPLReplimune Group
IMUXImmunic
PTGXProtagonist Therapeutics
ESTAEstablishment Labs Holdings

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering CVS Health

3 Months
Stephen Baxter
Stephen BaxterWells Fargo
Success Rate15/20 ratings generated profit
75%
Average Return
+12.01%
Follow Stephen Baxter

Copying Stephen Baxter's trades and holding each position for 3 Months would result in 75.00% of your transactions generating a profit, with an average return of +12.01% per trade.

1 Year
Stephen Baxter
Stephen BaxterWells Fargo
Success Rate17/20 ratings generated profit
85%
Average Return
+27.68%
Follow Stephen Baxter

Copying Stephen Baxter's trades and holding each position for 1 Year would result in 85.00% of your transactions generating a profit, with an average return of +27.68% per trade.

2 Years
Allen Lutz
Allen LutzBank of America Securities
Success Rate25/29 ratings generated profit
86%
Average Return
+34.14%
Follow Allen Lutz

Copying Allen Lutz's trades and holding each position for 2 Years would result in 86.21% of your transactions generating a profit, with an average return of +34.14% per trade.

1CVS Analyst Recommendation Trends

020406080Oct 25Nov 25Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26
Monthly rating counts for 1CVS
RatingMay 26Jun 26Jul 26Aug 26Sep 26
Strong Buy00000
Buy3437363532
Hold01110
Sell00000
Strong Sell00000
total3438373632

In the current month, 1CVS has received 32 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 1CVS average Analyst price target in the past 3 months is 102.93.

1CVS Financial Forecast

EUR -1EUR 0EUR 1EUR 2EUR 3Q4 2025Q2 2026Q3 2026
HighEUR 1.67
ConsensusEUR 1.48
LowEUR 1.36

1CVS Earnings Forecast

Next quarter’s earnings estimate for 1CVS is EUR 1.48 with a range of EUR 1.36 to EUR 1.67. The previous quarter’s EPS was EUR 2.31. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

EUR 89.8BEUR 91.7BEUR 93.6BEUR 95.5BEUR 97.4BQ4 2025Q2 2026Q3 2026
HighEUR 97.4B
ConsensusEUR 93.6B
LowEUR 91.5B

1CVS Sales Forecast

Next quarter’s sales forecast for 1CVS is EUR 93.63B with a range of EUR 91.51B to EUR 97.40B. The previous quarter’s sales results were EUR 94.87B. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

1CVS Stock Forecast FAQ

What is IT:1CVS’s average 12-month price target, according to analysts?
Based on analyst ratings, CVS Health’s 12-month average price target is €102.93.
What is IT:1CVS’s upside potential, based on the analysts’ average price target?
CVS Health has 30.29% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is CVS Health a Buy, Sell or Hold?
CVS Health has a consensus rating of Strong Buy, which is based on 16 buy ratings, 0 hold ratings and 0 sell ratings.
What is CVS Health’s share price target?
The average share price target for CVS Health is €102.93. This is based on 16 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is €112.37, and the lowest forecast is €96.18. The average share price target represents a 30.29% increase from the current price of €79.
What do analysts say about CVS Health?
CVS Health’s analyst rating consensus is a Strong Buy. This is based on the ratings of 16 Wall Street analysts.
How can I buy shares of CVS Health?
To buy shares of IT:1CVS, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.